-
DE
Bictegravir is an antiretroviral agent used to treat HIV-1 infection. It belongs to the class of integrase strand transfer inhibitors and is used in combination with other active substances.
Bictegravir is an antiretroviral agent used to treat HIV-1 infection. It belongs to the class of integrase strand transfer inhibitors and is used in combination with other active substances.
Bictegravir is an antiretroviral medication used in the treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection. It belongs to the drug class of integrase strand transfer inhibitors (INSTIs). In clinical practice, bictegravir is exclusively available as a fixed-dose combination with tenofovir alafenamide (TAF) and emtricitabine (FTC), marketed under the brand name Biktarvy.
HIV requires the enzyme integrase to insert its genetic material into the DNA of the human host cell. Bictegravir selectively blocks this step by inhibiting the catalytic activity of the integrase enzyme. This prevents the viral DNA from being permanently integrated into the host cell, thereby stopping the production of new virus copies. This mechanism is highly specific and has minimal impact on human cellular enzymes.
Bictegravir (as part of Biktarvy) is approved for use in:
The standard dose is one tablet (50 mg bictegravir / 200 mg emtricitabine / 25 mg tenofovir alafenamide) taken once daily, with or without food. The once-daily single-tablet regimen is designed to support medication adherence.
Bictegravir is generally well tolerated. Possible side effects include:
As with all antiretroviral medications, bictegravir can in rare cases cause lactic acidosis or worsening of pre-existing liver disease. Regular medical monitoring is recommended.
Bictegravir is primarily metabolized via the enzyme CYP3A4 and UGT1A1. Therefore, interactions may occur with the following substances:
Bictegravir should not be discontinued without medical guidance, as uncontrolled cessation can lead to the development of viral resistance and a rebound in viral load. Use during pregnancy requires careful benefit-risk assessment. Bictegravir is excreted in breast milk; breastfeeding is generally not recommended for HIV-positive mothers.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.